Back to results
US 2026/0286372 A1Published application
Targeted insertion via transposition
AssigneeDonald Danforth Plant Science Center
InventorsR. Keith Slotkin, Peng Liu
Life of this patent
Estimating the term…
Abstract
The present disclosure describes systems and methods for accurately inserting a donor polynucleotide into a target nucleic acid locus. The systems include a programmable targeting nuclease, a transposase, and a donor polynucleotide flanked by transposition sequences compatible with the transposase.
Claims21
An engineered nucleic acid modification system for generating a genetically modified soybean cell, the system comprising:
- a. a donor polynucleotide comprising a first and second mPing miniature inverted-repeat transposable element (MITE) transposition sequences;
- b. one or more nucleic acid constructs for expressing
- i. a Pong ORF1 protein of a Pong transposase, the nucleic acid construct comprising a promoter operably linked to a nucleic acid sequence encoding the Pong ORF1 protein;
- ii. a nucleic acid construct for expressing a targeting nuclease of a CRISPR/Cas system comprising a Cas nuclease and a guide RNA (gRNA), wherein the Cas nuclease is fused to the C-terminus of a Pong ORF2 protein of the Pong transposase by more than one copy of a flexible linker, the nucleic acid construct comprising a promoter operably linked to a nucleic acid sequence encoding the Cas nuclease fused to the C-terminus of the Pong ORF2 protein by more than one copy of a flexible linker;
- and
- iii. a nucleic acid expression construct for expressing the gRNA of the CRISPR/Cas system;
- wherein the CRISPR/Cas system is programmed to target the transposase and the donor polynucleotide to a target nucleic acid locus in the cell, to introduce a cut in the target nucleic acid locus, or both, thereby accomplishing insertion of the donor polynucleotide at the target nucleic acid locus to generate a genetically modified cell comprising the donor polynucleotide inserted at the target nucleic acid locus.
4 more elements
3-4. (canceled)
6-18. (canceled)
22-29. (canceled)
(canceled)
35-37. (canceled)
39-57. (canceled)
59-61. (canceled)
63-65. (canceled)
Dependencies are inferred from the claim text.